Acquired Hemophilia A and ST-Elevation Myocardial Infarction (STEMI): A Rare Presentation and Management Dilemma

Jevin Yabut; Gian Lima; Ritika Vankina; Swarup Kumar; Joyce Meng

doi:10.7759/cureus.38549

Acquired Hemophilia A and ST-Elevation Myocardial Infarction (STEMI): A Rare Presentation and Management Dilemma

Cureus. 2023 May 4;15(5):e38549. doi: 10.7759/cureus.38549. eCollection 2023 May.

Authors

Jevin Yabut¹, Gian Lima², Ritika Vankina³, Swarup Kumar³, Joyce Meng⁴

Affiliations

¹ Medicine, University of Connecticut, Farmington, USA.
² Internal Medicine, University of Connecticut, Farmington, USA.
³ Hematology and Oncology, University of Connecticut, Farmington, USA.
⁴ Cardiology, University of Connecticut, Farmington, USA.

Abstract

Thrombotic events are a rare complication of recombinant activated factor VII (rFVIIa) therapy in patients with hemophilia. We present a case of a 71-year-old male who developed ST-elevation myocardial infarction after receiving rFVIIa replacement therapy for acquired hemophilia A.

Keywords: acute coronary syndrome; coagulopathy; factor vii; factor vii replacement; factor viii deficiency; hemophilia a; novoseven; stemi.

Publication types

Case Reports